{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T08:19:44Z","timestamp":1768033184991,"version":"3.49.0"},"reference-count":39,"publisher":"Japanese Society of Toxicology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2131\/jts.51.45","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:10:53Z","timestamp":1767651053000},"page":"45-55","source":"Crossref","is-referenced-by-count":0,"title":["Perillyl alcohol-induced hematological modulations: insights into human blood cells damage, eryptosis, and systemic perturbations"],"prefix":"10.2131","volume":"51","author":[{"given":"Ahmed M.","family":"Basudan","sequence":"first","affiliation":[{"name":"Chair of Medical and Molecular Genetics Research, Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jawaher","family":"Alsughayyir","sequence":"additional","affiliation":[{"name":"Chair of Medical and Molecular Genetics Research, Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yazeed A.","family":"Al-Sheikh","sequence":"additional","affiliation":[{"name":"Chair of Medical and Molecular Genetics Research, Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad A.","family":"Alfhili","sequence":"additional","affiliation":[{"name":"Chair of Medical and Molecular Genetics Research, Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Alfhili, M.A., Alsalmi, E., Aljedai, A., Alsughayyir, J., Abudawood, M. and Basudan, A.M. (2022): Calcium-oxidative stress signaling axis and casein kinase 1\u03b1 mediate eryptosis and hemolysis elicited by novel p53 agonist inauhzin. J. Chemother., <b>34<\/b>, 247-257.","DOI":"10.1080\/1120009X.2021.1963616"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Alfhili, M.A. and Lee, M.H. (2021): Flow Cytofluorometric Analysis of Molecular Mechanisms of Premature Red Blood Cell Death. Methods Mol. Biol., <b>2326<\/b>, 155-165.","DOI":"10.1007\/978-1-0716-1514-0_11"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Alghareeb, S.A., Alfhili, M.A. and Fatima, S. (2023): Molecular Mechanisms and Pathophysiological Significance of Eryptosis. Int. J. Mol. Sci., <b>24<\/b>, 5079.","DOI":"10.3390\/ijms24065079"},{"key":"4","unstructured":"Ariazi, E.A., Satomi, Y., Ellis, M.J., Haag, J.D., Shi, W., Sattler, C.A. and Gould, M.N. (1999): Activation of the transforming growth factor beta signaling pathway and induction of cytostasis and apoptosis in mammary carcinomas treated with the anticancer agent perillyl alcohol. Cancer Res., <b>59<\/b>, 1917-1928."},{"key":"5","doi-asserted-by":"crossref","unstructured":"Armstrong, J.K., Meiselman, H.J. and Fisher, T.C. (1997): Covalent binding of poly(ethylene glycol) (PEG) to the surface of red blood cells inhibits aggregation and reduces low shear blood viscosity. Am. J. Hematol., <b>56<\/b>, 26-28.","DOI":"10.1002\/(SICI)1096-8652(199709)56:1<26::AID-AJH5>3.0.CO;2-4"},{"key":"6","unstructured":"Belanger, J.T. (1998): Perillyl alcohol: applications in oncology. Altern. Med. Rev., <b>3<\/b>, 448-457."},{"key":"7","doi-asserted-by":"publisher","unstructured":"Chen, T.C., da Fonseca, C.O., Levin, D. and Sch\u00f6nthal, A.H. (2021): The Monoterpenoid Perillyl Alcohol: Anticancer Agent and Medium to Overcome Biological Barriers. Pharmaceutics, <b>13<\/b>, 2167.","DOI":"10.3390\/pharmaceutics13122167"},{"key":"8","unstructured":"Chen, T.C., Fonseca, C.O. and Sch\u00f6nthal, A.H. (2015): Preclinical development and clinical use of perillyl alcohol for chemoprevention and cancer therapy. Am. J. Cancer Res., <b>5<\/b>, 1580-1593."},{"key":"9","doi-asserted-by":"crossref","unstructured":"da Fonseca, C.O., Schwartsmann, G., Fischer, J., Nagel, J., Futuro, D., Quirico-Santos, T. and Gattass, C.R. (2008): Preliminary results from a phase I\/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas. Surg. Neurol., <b>70<\/b>, 259-266, discussion, 266-267.","DOI":"10.1016\/j.surneu.2007.07.040"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Dur\u00e7o, A.O., Concei\u00e7\u00e3o, L.S.R., de Souza, D.S., Lima, C.A., Quintans, J. de S.S. and Viana dos Santos, M.R. (2021): Perillyl alcohol as a treatment for cancer: A systematic review. Phytomed. Plus, <b>1<\/b>, 100090.","DOI":"10.1016\/j.phyplu.2021.100090"},{"key":"11","doi-asserted-by":"crossref","unstructured":"F\u00f6ller, M., Huber, S.M. and Lang, F. (2008): Erythrocyte programmed cell death. IUBMB Life, <b>60<\/b>, 661-668.","DOI":"10.1002\/iub.106"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Franchini, M., Targher, G., Montagnana, M. and Lippi, G. (2008): Iron and thrombosis. Ann. Hematol., <b>87<\/b>, 167-173.","DOI":"10.1007\/s00277-007-0416-1"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Garcia, D.G., Amorim, L.M., de Castro Faria, M.V., Freire, A.S., Santelli, R.E., Da Fonseca, C.O., Quirico-Santos, T. and Burth, P. (2010): The anticancer drug perillyl alcohol is a Na\/K-ATPase inhibitor. Mol. Cell. Biochem., <b>345<\/b>, 29-34.","DOI":"10.1007\/s11010-010-0556-9"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Guerrero-Hue, M., Rubio-Navarro, A., Sevillano, \u00c1., Yuste, C., Guti\u00e9rrez, E., Palomino-Antol\u00edn, A., Rom\u00e1n, E., Praga, M., Egido, J. and Moreno, J.A. (2018): Efectos adversos de la acumulaci\u00f3n renal de hemoprote\u00ednas. Nuevas herramientas terap\u00e9uticas. Nefrologia (Engl. Ed.), <b>38<\/b>, 13-26.","DOI":"10.1016\/j.nefro.2017.05.009"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Haag, J.D. and Gould, M.N. (1994): Mammary carcinoma regression induced by perillyl alcohol, a hydroxylated analog of limonene. Cancer Chemother. Pharmacol., <b>34<\/b>, 477-483.","DOI":"10.1007\/BF00685658"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Hohl, R.J. and Lewis, K. (1995): Differential effects of monoterpenes and lovastatin on RAS processing. J. Biol. Chem., <b>270<\/b>, 17508-17512.","DOI":"10.1074\/jbc.270.29.17508"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Jema\u00e0, M., Fezai, M., Bissinger, R. and Lang, F. (2017): Methods Employed in Cytofluorometric Assessment of Eryptosis, the Suicidal Erythrocyte Death. Cell. Physiol. Biochem., <b>43<\/b>, 431-444.","DOI":"10.1159\/000480469"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Kameneva, M.V., Repko, B.M., Krasik, E.F., Perricelli, B.C. and Borovetz, H.S. (2003): Polyethylene glycol additives reduce hemolysis in red blood cell suspensions exposed to mechanical stress. ASAIO J., <b>49<\/b>, 537-542.","DOI":"10.1097\/01.MAT.0000084176.30221.CF"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Khazal, S., Galvez Silva, J. R., Thakar, M. and Margolis, D. (2023): Bone Marrow Failure. Critical Care of the Pediatric Immunocompromised Hematology\/Oncology Patient: An Evidence-Based Guide, 95-107.","DOI":"10.1007\/978-3-030-01322-6_7"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Lang, F. and Qadri, S.M. (2012): Mechanisms and significance of eryptosis, the suicidal death of erythrocytes. Blood Purif., <b>33<\/b>, 125-130.","DOI":"10.1159\/000334163"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Lang, K.S., Roll, B., Myssina, S., Schittenhelm, M., Scheel-Walter, H.G., Kanz, L., Fritz, J., Lang, F., Huber, S.M. and Wieder, T. (2002): Enhanced erythrocyte apoptosis in sickle cell anemia, thalassemia and glucose-6-phosphate dehydrogenase deficiency. Cell. Physiol. Biochem., <b>12<\/b>, 365-372.","DOI":"10.1159\/000067907"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Lang, P.A., Beringer, O., Nicolay, J.P., Amon, O., Kempe, D.S., Hermle, T., Attanasio, P., Akel, A., Sch\u00e4fer, R., Friedrich, B., Risler, T., Baur, M., Olbricht, C.J., Zimmerhackl, L.B., Zipfel, P.F., Wieder, T. and Lang, F. (2006): Suicidal death of erythrocytes in recurrent hemolytic uremic syndrome. J. Mol. Med. (Berl.), <b>84<\/b>, 378-388.","DOI":"10.1007\/s00109-006-0058-0"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Lantry, L.E., Zhang, Z., Gao, F., Crist, K.A., Wang, Y., Kelloff, G.J., Lubet, R.A. and You, M. (1997): Chemopreventive effect of perillyl alcohol on 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanone induced tumorigenesis in (C3H\/HeJ X A\/J)F1 mouse lung. J. Cell. Biochem., <b>67<\/b> (SUPPL. 27), 20-25.","DOI":"10.1002\/(SICI)1097-4644(1997)27+<20::AID-JCB6>3.3.CO;2-A"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Loutrari, H., Hatziapostolou, M., Skouridou, V., Papadimitriou, E., Roussos, C., Kolisis, F.N. and Papapetropoulos, A. (2004): Perillyl alcohol is an angiogenesis inhibitor. J. Pharmacol. Exp. Ther., <b>311<\/b>, 568-575.","DOI":"10.1124\/jpet.104.070516"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Ma, J., Li, J., Wang, K.S., Mi, C., Piao, L.X., Xu, G.H., Li, X., Lee, J.J. and Jin, X. (2016): Perillyl alcohol efficiently scavenges activity of cellular ROS and inhibits the translational expression of hypoxia-inducible factor-1\u03b1 via mTOR\/4E-BP1 signaling pathways. Int. Immunopharmacol., <b>39<\/b>, 1-9.","DOI":"10.1016\/j.intimp.2016.06.034"},{"key":"26","unstructured":"Mills, J.J., Chari, R.S., Boyer, I.J., Gould, M.N. and Jirtle, R.L. (1995): Induction of apoptosis in liver tumors by the monoterpene perillyl alcohol. Cancer Res., <b>55<\/b>, 979-983."},{"key":"27","doi-asserted-by":"crossref","unstructured":"Peczek, S.H., Tartari, A.P., Zittlau, I.C., Diedrich, C., Machado, C.S. and Mainardes, R.M. (2023): Enhancing Oral Bioavailability and Brain Biodistribution of Perillyl Alcohol Using Nanostructured Lipid Carriers. Pharmaceuticals (Basel), <b>16<\/b>, 1055.","DOI":"10.3390\/ph16081055"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Premont, R.T., Reynolds, J.D., Zhang, R. and Stamler, J.S. (2020): Role of Nitric Oxide Carried by Hemoglobin in Cardiovascular Physiology: Developments on a Three-Gas Respiratory Cycle. Circ. Res., <b>126<\/b>, 129-158.","DOI":"10.1161\/CIRCRESAHA.119.315626"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Rajesh, D., Stenzel, R.A. and Howard, S.P. (2003): Perillyl alcohol as a radio-\/chemosensitizer in malignant glioma. J. Biol. Chem., <b>278<\/b>, 35968-35978.","DOI":"10.1074\/jbc.M303280200"},{"key":"30","unstructured":"Reddy, B.S., Wang, C.X., Samaha, H., Lubet, R., Steele, V.E., Kelloff, G.J. and Rao, C.V. (1997): Chemoprevention of colon carcinogenesis by dietary perillyl alcohol. Cancer Res., <b>57<\/b>, 420-425."},{"key":"31","doi-asserted-by":"crossref","unstructured":"Repsold, L. and Joubert, A.M. (2018): Eryptosis: An Erythrocyte\u2019s Suicidal Type of Cell Death. BioMed Res. Int., <b>2018<\/b>, 9405617.","DOI":"10.1155\/2018\/9405617"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Rossi, A.M. and Taylor, C.W. (2020): Reliable measurement of free Ca<sup>2+<\/sup> concentrations in the ER lumen using Mag-Fluo-4. Cell Calcium, <b>87<\/b>, 102188.","DOI":"10.1016\/j.ceca.2020.102188"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Santos, J.G., Da Cruz, W.M., Sch\u00f6nthal, A.H., Salazar, M.D., Fontes, C.A., Quirico-Santos, T. and Da Fonseca, C.O. (2018): Efficacy of a ketogenic diet with concomitant intranasal perillyl alcohol as a novel strategy for the therapy of recurrent glioblastoma. Oncol. Lett., <b>15<\/b>, 1263-1270.","DOI":"10.3892\/ol.2017.7362"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Stark, M.J., Burke, Y.D., McKinzie, J.H., Ayoubi, A.S. and Crowell, P.L. (1995): Chemotherapy of pancreatic cancer with the monoterpene perillyl alcohol. Cancer Lett., <b>96<\/b>, 15-21.","DOI":"10.1016\/0304-3835(95)03912-G"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Tkachenko, A., Alfhili, M.A., Alsughayyir, J., Attanzio, A., Al, A., Bhuyan, M., Bukowska, B., Cilla, A., Quintanar-Escorza, M.A., F\u00f6ller, M., Havranek, O., Jilani, K., Onishchenko, A., Pretorius, E., Prokopiuk, V., Restivo, I., Tesoriere, L., Virz\u00ec, G.M. and Wieder, T. (2025a): Current understanding of eryptosis: mechanisms, physiological functions, role in disease, pharmacological applications, and nomenclature recommendations. Cell Death Dis., <b>16<\/b>, 1-36.","DOI":"10.1038\/s41419-025-07784-w"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Tkachenko, A., Alfhili, M.A., Alsughayyir, J., Attanzio, A., Bhuyan, A.A., Bukowska, B., Cilla, A., Quintanar-Escorza, M.A., F\u00f6ller, M., Havranek, O., Jilani, K., Onishchenko, A., Pretorius, E., Prokopiuk, V., Restivo, I., Tesoriere, L., Virz\u00ec, G.M. and Wieder, T. (2025b): Current understanding of eryptosis: mechanisms, physiological functions, role in disease, pharmacological applications, and nomenclature recommendations. Cell Death Dis., <b>16<\/b>, 467.","DOI":"10.1038\/s41419-025-07784-w"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Xu, M., Floyd, H.S., Greth, S.M., Chang, W.C., Lohman, K., Stoyanova, R., Kucera, G.L., Kute, T.E., Willingham, M.C. and Miller, M.S. (2004): Perillyl alcohol-mediated inhibition of lung cancer cell line proliferation: potential mechanisms for its chemotherapeutic effects. Toxicol. Appl. Pharmacol., <b>195<\/b>, 232-246.","DOI":"10.1016\/j.taap.2003.11.013"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Yuri, T., Danbara, N., Tsujita-Kyutoku, M., Kiyozuka, Y., Senzaki, H., Shikata, N., Kanzaki, H. and Tsubura, A. (2004): Perillyl alcohol inhibits human breast cancer cell growth <i>in vitro<\/i> and <i>in vivo.<\/i> Breast Cancer Res. Treat., <b>84<\/b>, 251-260.","DOI":"10.1023\/B:BREA.0000019966.97011.4d"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Zappulla, D. (2008): Environmental stress, erythrocyte dysfunctions, inflammation, and the metabolic syndrome: adaptations to CO2 increases? J. Cardiometab. Syndr., <b>3<\/b>, 30-34.","DOI":"10.1111\/j.1559-4572.2008.07263.x"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/51\/1\/51_45\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T04:12:07Z","timestamp":1768018327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/51\/1\/51_45\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.51.45","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}